Osamu Kurasawa
3PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|May 22, 2021
A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery.Kenichi Iwai, Tadahiro Nambu, Yukie Kashima
|Jan 03, 2020
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent.Osamu Kurasawa, Tohru Miyazaki, Misaki Homma
|May 28, 2019
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor.Kenichi Iwai, Tadahiro Nambu, Ryo Dairiki
Pageof 1
Frequent Collaborators
2 joint publications
Kenichi Iwai
2 joint publications
Tadahiro Nambu
2 joint publications
Jie Yu
2 joint publications
Huifeng Niu
2 joint publications
Akihiro Ohashi
1 joint publications
Kristine Burke
1 joint publications
Shunsuke Ebara
1 joint publications
Sachio Shibata
1 joint publications
Takashi Imada
1 joint publications
Nobuo Cho
